Madison Pereira, Kathy Matuszewska, Colin Jamieson, Jim Petrik. Front Endocrinol (Lausanne) 2021
Times Cited: 1
Times Cited: 1
Times Cited
Times Co-cited
Similarity
Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers.
Robert L Coleman, Russell R Broaddus, Diane C Bodurka, Judith K Wolf, Thomas W Burke, John J Kavanagh, Charles F Levenback, David M Gershenson. Gynecol Oncol 2006
Robert L Coleman, Russell R Broaddus, Diane C Bodurka, Judith K Wolf, Thomas W Burke, John J Kavanagh, Charles F Levenback, David M Gershenson. Gynecol Oncol 2006
100
Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.
Srinivas Malladi, Danilo G Macalinao, Xin Jin, Lan He, Harihar Basnet, Yilong Zou, Elisa de Stanchina, Joan Massagué. Cell 2016
Srinivas Malladi, Danilo G Macalinao, Xin Jin, Lan He, Harihar Basnet, Yilong Zou, Elisa de Stanchina, Joan Massagué. Cell 2016
100
Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
Karen McLean, Lijun Tan, Danielle E Bolland, Lan G Coffman, Luke F Peterson, Moshe Talpaz, Nouri Neamati, Ronald J Buckanovich. Oncogene 2019
Karen McLean, Lijun Tan, Danielle E Bolland, Lan G Coffman, Luke F Peterson, Moshe Talpaz, Nouri Neamati, Ronald J Buckanovich. Oncogene 2019
100
Post-transcriptional regulations of cancer stem cell homeostasis.
Nabila Berabez, Sébastien Durand, Mathieu Gabut. Curr Opin Oncol 2019
Nabila Berabez, Sébastien Durand, Mathieu Gabut. Curr Opin Oncol 2019
100
Influence of Innate Immunity on Cancer Cell Stemness.
Anna Pastò, Francesca Maria Consonni, Antonio Sica. Int J Mol Sci 2020
Anna Pastò, Francesca Maria Consonni, Antonio Sica. Int J Mol Sci 2020
100
Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment.
Kosuke Akiyama, Noritaka Ohga, Yasuhiro Hida, Taisuke Kawamoto, Yoshihiro Sadamoto, Shuhei Ishikawa, Nako Maishi, Tomoshige Akino, Miyako Kondoh, Aya Matsuda,[...]. Am J Pathol 2012
Kosuke Akiyama, Noritaka Ohga, Yasuhiro Hida, Taisuke Kawamoto, Yoshihiro Sadamoto, Shuhei Ishikawa, Nako Maishi, Tomoshige Akino, Miyako Kondoh, Aya Matsuda,[...]. Am J Pathol 2012
100
MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1.
Katja Engelmann, Hongmei Shen, Olivera J Finn. Cancer Res 2008
Katja Engelmann, Hongmei Shen, Olivera J Finn. Cancer Res 2008
100
Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma.
Terence Kin-Wah Lee, Vincent Chi-Ho Cheung, Ping Lu, Eunice Yuen Ting Lau, Stephanie Ma, Kwan Ho Tang, Man Tong, Jessica Lo, Irene Oi Lin Ng. Hepatology 2014
Terence Kin-Wah Lee, Vincent Chi-Ho Cheung, Ping Lu, Eunice Yuen Ting Lau, Stephanie Ma, Kwan Ho Tang, Man Tong, Jessica Lo, Irene Oi Lin Ng. Hepatology 2014
100
Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer.
Jin-Gyoung Jung, Alexander Stoeck, Bin Guan, Ren-Chin Wu, Heng Zhu, Seth Blackshaw, Ie-Ming Shih, Tian-Li Wang. PLoS Genet 2014
Jin-Gyoung Jung, Alexander Stoeck, Bin Guan, Ren-Chin Wu, Heng Zhu, Seth Blackshaw, Ie-Ming Shih, Tian-Li Wang. PLoS Genet 2014
100
Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer.
Jessica Gobbo, Guillaume Marcion, Marine Cordonnier, Alexandre M M Dias, Nicolas Pernet, Arlette Hammann, Sarah Richaud, Hajare Mjahed, Nicolas Isambert, Victor Clausse,[...]. J Natl Cancer Inst 2015
Jessica Gobbo, Guillaume Marcion, Marine Cordonnier, Alexandre M M Dias, Nicolas Pernet, Arlette Hammann, Sarah Richaud, Hajare Mjahed, Nicolas Isambert, Victor Clausse,[...]. J Natl Cancer Inst 2015
100
Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.
Adam D Steg, Kerri S Bevis, Ashwini A Katre, Angela Ziebarth, Zachary C Dobbin, Ronald D Alvarez, Kui Zhang, Michael Conner, Charles N Landen. Clin Cancer Res 2012
Adam D Steg, Kerri S Bevis, Ashwini A Katre, Angela Ziebarth, Zachary C Dobbin, Ronald D Alvarez, Kui Zhang, Michael Conner, Charles N Landen. Clin Cancer Res 2012
100
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer.
Junzo Hamanishi, Masaki Mandai, Masashi Iwasaki, Taku Okazaki, Yoshimasa Tanaka, Ken Yamaguchi, Toshihiro Higuchi, Haruhiko Yagi, Kenji Takakura, Nagahiro Minato,[...]. Proc Natl Acad Sci U S A 2007
Junzo Hamanishi, Masaki Mandai, Masashi Iwasaki, Taku Okazaki, Yoshimasa Tanaka, Ken Yamaguchi, Toshihiro Higuchi, Haruhiko Yagi, Kenji Takakura, Nagahiro Minato,[...]. Proc Natl Acad Sci U S A 2007
100
Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression.
Kristy K Ward, Isabelle Tancioni, Christine Lawson, Nichol L G Miller, Christine Jean, Xiao Lei Chen, Sean Uryu, Josephine Kim, David Tarin, Dwayne G Stupack,[...]. Clin Exp Metastasis 2013
Kristy K Ward, Isabelle Tancioni, Christine Lawson, Nichol L G Miller, Christine Jean, Xiao Lei Chen, Sean Uryu, Josephine Kim, David Tarin, Dwayne G Stupack,[...]. Clin Exp Metastasis 2013
100
SOX2 is required to maintain cancer stem cells in ovarian cancer.
Yiping Wen, Yaya Hou, Zaiju Huang, Jing Cai, Zehua Wang. Cancer Sci 2017
Yiping Wen, Yaya Hou, Zaiju Huang, Jing Cai, Zehua Wang. Cancer Sci 2017
100
Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma.
Furong Dai, Yi Zhang, Yuxiang Chen. Hum Pathol 2014
Furong Dai, Yi Zhang, Yuxiang Chen. Hum Pathol 2014
100
LncRNA AWPPH promotes the proliferation, migration and invasion of ovarian carcinoma cells via activation of the Wnt/β‑catenin signaling pathway.
Guangyu Yu, Wenshuang Wang, Junfeng Deng, Shaohua Dong. Mol Med Rep 2019
Guangyu Yu, Wenshuang Wang, Junfeng Deng, Shaohua Dong. Mol Med Rep 2019
100
First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors.
Gerald Falchook, Jeffrey Infante, Hendrik-Tobias Arkenau, Manish R Patel, Emma Dean, Erkut Borazanci, Andrew Brenner, Natalie Cook, Juanita Lopez, Shubham Pant,[...]. EClinicalMedicine 2021
Gerald Falchook, Jeffrey Infante, Hendrik-Tobias Arkenau, Manish R Patel, Emma Dean, Erkut Borazanci, Andrew Brenner, Natalie Cook, Juanita Lopez, Shubham Pant,[...]. EClinicalMedicine 2021
100
Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells.
Ayesha B Alvero, Michele K Montagna, Jennie C Holmberg, Vinicius Craveiro, David Brown, Gil Mor. Mol Cancer Ther 2011
Ayesha B Alvero, Michele K Montagna, Jennie C Holmberg, Vinicius Craveiro, David Brown, Gil Mor. Mol Cancer Ther 2011
100
100
Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments.
Shreya Raghavan, Pooja Mehta, Yuying Xie, Yu L Lei, Geeta Mehta. J Immunother Cancer 2019
Shreya Raghavan, Pooja Mehta, Yuying Xie, Yu L Lei, Geeta Mehta. J Immunother Cancer 2019
100
Dual roles of immune cells and their factors in cancer development and progression.
Brian F Zamarron, WanJun Chen. Int J Biol Sci 2011
Brian F Zamarron, WanJun Chen. Int J Biol Sci 2011
100
Latent bone metastasis in breast cancer tied to Src-dependent survival signals.
Xiang H-F Zhang, Qiongqing Wang, William Gerald, Clifford A Hudis, Larry Norton, Marcel Smid, John A Foekens, Joan Massagué. Cancer Cell 2009
Xiang H-F Zhang, Qiongqing Wang, William Gerald, Clifford A Hudis, Larry Norton, Marcel Smid, John A Foekens, Joan Massagué. Cancer Cell 2009
100
Active PI3K pathway causes an invasive phenotype which can be reversed or promoted by blocking the pathway at divergent nodes.
Jeffrey J Wallin, Jane Guan, Kyle A Edgar, Wei Zhou, Ross Francis, Anthony C Torres, Peter M Haverty, Jeffrey Eastham-Anderson, Sabrina Arena, Alberto Bardelli,[...]. PLoS One 2012
Jeffrey J Wallin, Jane Guan, Kyle A Edgar, Wei Zhou, Ross Francis, Anthony C Torres, Peter M Haverty, Jeffrey Eastham-Anderson, Sabrina Arena, Alberto Bardelli,[...]. PLoS One 2012
100
The identification of the biological characteristics of human ovarian cancer stem cells.
H C Yan, L S Fang, J Xu, Y Y Qiu, X M Lin, H X Huang, Q Y Han. Eur Rev Med Pharmacol Sci 2014
H C Yan, L S Fang, J Xu, Y Y Qiu, X M Lin, H X Huang, Q Y Han. Eur Rev Med Pharmacol Sci 2014
100
Role of Magmas in protein transport and human mitochondria biogenesis.
Devanjan Sinha, Neha Joshi, Balasubramanyam Chittoor, Priyanka Samji, Patrick D'Silva. Hum Mol Genet 2010
Devanjan Sinha, Neha Joshi, Balasubramanyam Chittoor, Priyanka Samji, Patrick D'Silva. Hum Mol Genet 2010
100
Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor-Based Immunotherapy and Chemotherapy.
Rüdiger Klapdor, Shuo Wang, Ulrich Hacker, Hildegard Büning, Michael Morgan, Thilo Dörk, Peter Hillemanns, Axel Schambach. Hum Gene Ther 2017
Rüdiger Klapdor, Shuo Wang, Ulrich Hacker, Hildegard Büning, Michael Morgan, Thilo Dörk, Peter Hillemanns, Axel Schambach. Hum Gene Ther 2017
100
Dormant disseminated tumor cells and cancer stem/progenitor-like cells: Similarities and opportunities.
Omri Hen, Dalit Barkan. Semin Cancer Biol 2020
Omri Hen, Dalit Barkan. Semin Cancer Biol 2020
100
An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population.
Ram K Singh, Ajit Dhadve, Asmita Sakpal, Abhijit De, Pritha Ray. Sci Rep 2016
Ram K Singh, Ajit Dhadve, Asmita Sakpal, Abhijit De, Pritha Ray. Sci Rep 2016
100
The role of cancer stem cells in the modulation of anti-tumor immune responses.
Cristina Maccalli, Kakil Ibrahim Rasul, Mamoun Elawad, Soldano Ferrone. Semin Cancer Biol 2018
Cristina Maccalli, Kakil Ibrahim Rasul, Mamoun Elawad, Soldano Ferrone. Semin Cancer Biol 2018
100
Ovarian cancer stem cells and targeted therapy.
Vahideh Keyvani, Moein Farshchian, Seyed-Alireza Esmaeili, Hadi Yari, Meysam Moghbeli, Seyed-Reza Kazemi Nezhad, Mohammad Reza Abbaszadegan. J Ovarian Res 2019
Vahideh Keyvani, Moein Farshchian, Seyed-Alireza Esmaeili, Hadi Yari, Meysam Moghbeli, Seyed-Reza Kazemi Nezhad, Mohammad Reza Abbaszadegan. J Ovarian Res 2019
100
Immunobiology of mesenchymal stem cells.
S Ma, N Xie, W Li, B Yuan, Y Shi, Y Wang. Cell Death Differ 2014
S Ma, N Xie, W Li, B Yuan, Y Shi, Y Wang. Cell Death Differ 2014
100
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
Robert J Kurman, Ie-Ming Shih. Am J Surg Pathol 2010
Robert J Kurman, Ie-Ming Shih. Am J Surg Pathol 2010
100
Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications.
Francesca Nazio, Matteo Bordi, Valentina Cianfanelli, Franco Locatelli, Francesco Cecconi. Cell Death Differ 2019
Francesca Nazio, Matteo Bordi, Valentina Cianfanelli, Franco Locatelli, Francesco Cecconi. Cell Death Differ 2019
100
Dendritic cell rehab: new strategies to unleash therapeutic immunity in ovarian cancer.
Chang-Suk Chae, Eli Teran-Cabanillas, Juan R Cubillos-Ruiz. Cancer Immunol Immunother 2017
Chang-Suk Chae, Eli Teran-Cabanillas, Juan R Cubillos-Ruiz. Cancer Immunol Immunother 2017
100
Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
Anil Belur Nagaraj, Peronne Joseph, Olga Kovalenko, Sareena Singh, Amy Armstrong, Raymond Redline, Kimberly Resnick, Kristine Zanotti, Steven Waggoner, Analisa DiFeo. Oncotarget 2015
Anil Belur Nagaraj, Peronne Joseph, Olga Kovalenko, Sareena Singh, Amy Armstrong, Raymond Redline, Kimberly Resnick, Kristine Zanotti, Steven Waggoner, Analisa DiFeo. Oncotarget 2015
100
beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis.
M Saegusa, M Hashimura, T Yoshida, I Okayasu. Br J Cancer 2001
M Saegusa, M Hashimura, T Yoshida, I Okayasu. Br J Cancer 2001
100
KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma.
Yvonne T Tsang, Michael T Deavers, Charlotte C Sun, Suet-Yan Kwan, Eric Kuo, Anais Malpica, Samuel C Mok, David M Gershenson, Kwong-Kwok Wong. J Pathol 2013
Yvonne T Tsang, Michael T Deavers, Charlotte C Sun, Suet-Yan Kwan, Eric Kuo, Anais Malpica, Samuel C Mok, David M Gershenson, Kwong-Kwok Wong. J Pathol 2013
100
Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer.
Don S Dizon, Lars Damstrup, Neil J Finkler, Ulrik Lassen, Paul Celano, Ros Glasspool, Elizabeth Crowley, Henri S Lichenstein, Poul Knoblach, Richard T Penson. Int J Gynecol Cancer 2012
Don S Dizon, Lars Damstrup, Neil J Finkler, Ulrik Lassen, Paul Celano, Ros Glasspool, Elizabeth Crowley, Henri S Lichenstein, Poul Knoblach, Richard T Penson. Int J Gynecol Cancer 2012
100
Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress.
Carman K M Ip, Shan-Shan Li, Matthew Y H Tang, Samuel K H Sy, Yong Ren, Ho Cheung Shum, Alice S T Wong. Sci Rep 2016
Carman K M Ip, Shan-Shan Li, Matthew Y H Tang, Samuel K H Sy, Yong Ren, Ho Cheung Shum, Alice S T Wong. Sci Rep 2016
100
Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity.
Appalaraju Jaggupilli, Eyad Elkord. Clin Dev Immunol 2012
Appalaraju Jaggupilli, Eyad Elkord. Clin Dev Immunol 2012
100
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness.
Kha-Liang Lee, Yung-Che Kuo, Yuan-Soon Ho, Yen-Hua Huang. Cancers (Basel) 2019
Kha-Liang Lee, Yung-Che Kuo, Yuan-Soon Ho, Yen-Hua Huang. Cancers (Basel) 2019
100
Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway.
C Guo, X Wang, L-P Chen, M Li, M Li, Y-H Hu, W-H Ding, X Wang. Eur Rev Med Pharmacol Sci 2018
C Guo, X Wang, L-P Chen, M Li, M Li, Y-H Hu, W-H Ding, X Wang. Eur Rev Med Pharmacol Sci 2018
100
Ovarian cancer stem-like cells elicit the polarization of M2 macrophages.
Qing Zhang, Da-Jun Cai, Bin Li. Mol Med Rep 2015
Qing Zhang, Da-Jun Cai, Bin Li. Mol Med Rep 2015
100
Immune vulnerability of ovarian cancer stem-like cells due to low CD47 expression is protected by surrounding bulk tumor cells.
Chih-Long Chang, Chao-Chih Wu, Yun-Ting Hsu, Yi-Chiung Hsu. Oncoimmunology 2020
Chih-Long Chang, Chao-Chih Wu, Yun-Ting Hsu, Yi-Chiung Hsu. Oncoimmunology 2020
100
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.
Da Yang, Yan Sun, Limei Hu, Hong Zheng, Ping Ji, Chad V Pecot, Yanrui Zhao, Sheila Reynolds, Hanyin Cheng, Rajesha Rupaimoole,[...]. Cancer Cell 2013
Da Yang, Yan Sun, Limei Hu, Hong Zheng, Ping Ji, Chad V Pecot, Yanrui Zhao, Sheila Reynolds, Hanyin Cheng, Rajesha Rupaimoole,[...]. Cancer Cell 2013
100
Mitophagy, Mitochondrial Homeostasis, and Cell Fate.
Kaili Ma, Guo Chen, Wenhui Li, Oliver Kepp, Yushan Zhu, Quan Chen. Front Cell Dev Biol 2020
Kaili Ma, Guo Chen, Wenhui Li, Oliver Kepp, Yushan Zhu, Quan Chen. Front Cell Dev Biol 2020
100
Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy.
Ilio Vitale, Antonella Sistigu, Gwenola Manic, Nils-Petter Rudqvist, Zlatko Trajanoski, Lorenzo Galluzzi. Trends Cell Biol 2019
Ilio Vitale, Antonella Sistigu, Gwenola Manic, Nils-Petter Rudqvist, Zlatko Trajanoski, Lorenzo Galluzzi. Trends Cell Biol 2019
100
Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752.
XiuXiu Chen, LiHua Gong, RongYing Ou, ZhenZhen Zheng, JinYan Chen, FengFeng Xie, XiaoXiu Huang, JianGe Qiu, WenJi Zhang, QiWei Jiang,[...]. Gynecol Oncol 2016
XiuXiu Chen, LiHua Gong, RongYing Ou, ZhenZhen Zheng, JinYan Chen, FengFeng Xie, XiaoXiu Huang, JianGe Qiu, WenJi Zhang, QiWei Jiang,[...]. Gynecol Oncol 2016
100
ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients.
Roger W McGilvray, Robert A Eagle, Phil Rolland, Insiya Jafferji, John Trowsdale, Lindy G Durrant. Int J Cancer 2010
Roger W McGilvray, Robert A Eagle, Phil Rolland, Insiya Jafferji, John Trowsdale, Lindy G Durrant. Int J Cancer 2010
100
Ovarian cancer stem cell-specific gene expression profiling and targeted drug prescreening.
Yuting Huang, Baohui Ju, Jing Tian, Fenghua Liu, Hu Yu, Huiting Xiao, Xiangyu Liu, Wenxin Liu, Zhi Yao, Quan Hao. Oncol Rep 2014
Yuting Huang, Baohui Ju, Jing Tian, Fenghua Liu, Hu Yu, Huiting Xiao, Xiangyu Liu, Wenxin Liu, Zhi Yao, Quan Hao. Oncol Rep 2014
100
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.